SOLIGENIX, INC. — Director's Dealing 2007

Oct 1, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2007-09-27

Reporting Person: Buhrman Cyrille F (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-09-27	Stock Options (right to buy)	$0.36	A	75000	Acquired	2017-09-26	Common Stock (75000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4900020	Direct

Footnotes

F1: Stock options awarded for re-election to the Board of Directors.